TOXICOGENOMICS.

Slides:



Advertisements
Similar presentations
Martin John Bishop UK HGMP Resource Centre Hinxton Cambridge CB10 1 SB
Advertisements

DNA Damage and Repair. = ??? It is well-known that DNA can be damaged by radiation. However, DNA is routinely damaged by oxidative stress of normal cellular.
1 ère Journée de Biologie Systémique Université Paris 5 La Biologie des Systèmes en Toxicologie Robert Barouki UMR-S 747 INSERM Université Paris 5 Pharmacologie.
Statistical methods and tools for integrative analysis of perturbation signatures Mario Medvedovic Laboratory for Statistical Genomics and Systems Biology.
CSE Fall. Summary Goal: infer models of transcriptional regulation with annotated molecular interaction graphs The attributes in the model.
Data integration across omics landscapes Bing Zhang, Ph.D. Department of Biomedical Informatics Vanderbilt University School of Medicine
©2007 RALPH SNYDERMAN Third Annual Prospective Health Care Conference "Where are We Now?" Ralph Snyderman, MD Chancellor Emeritus, Duke University November.
Cardiovascular Continuum Sampling from Extremes Padmanabhan S et al. PLoS Genet 2011.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
1 SIMG Florence ppt The Horizons of Predictive Medicine Dr Ian Gilham Worldwide Director, Predictive Medicine Glaxo Wellcome Research and Development.
Diverse group of microbial ecologists, molecular biologists, biogeochemists, chemists, toxicologists, system biologists, geneticists.
Strengths in OMICS as a tool for the early detection of an environmental stressor Microbial Response Session 2009 EPA Fellowship Conference Sept. 22, 2009.
The Golden Age of Biology DNA -> RNA -> Proteins -> Metabolites Genomics Technologies MECHANISMS OF LIFE Health Care Diagnostics Medicines Animal Products.
Biology and Bioinformatics Gabor T. Marth Department of Biology, Boston College BI820 – Seminar in Quantitative and Computational Problems.
27803::Systems Biology1CBS, Department of Systems Biology Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break.
Computational Molecular Biology (Spring’03) Chitta Baral Professor of Computer Science & Engg.
Bioinformatics: a Multidisciplinary Challenge Ron Y. Pinter Dept. of Computer Science Technion March 12, 2003.
Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break 14:45 – 15:15Regulatory pathways lecture 15:15 – 15:45Exercise.
The Cell, Central Dogma and Human Genome Project.
Integrated analysis of regulatory and metabolic networks reveals novel regulatory mechanisms in Saccharomyces cerevisiae Speaker: Zhu YANG 6 th step, 2006.
10 Genomics, Proteomics and Genetic Engineering. 2 Genomics and Proteomics The field of genomics deals with the DNA sequence, organization, function,
27803::Systems Biology1CBS, Department of Systems Biology Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break.
What Do Toxicologists Do?
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Pharmacogenomics and personalized medicines Jean-Marie Boeynaems
Paola CASTAGNOLI Maria FOTI Microarrays. Applicazioni nella genomica funzionale e nel genotyping DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE.
BTN323: INTRODUCTION TO BIOLOGICAL DATABASES Day2: Specialized Databases Lecturer: Junaid Gamieldien, PhD
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 13 – BIOMARKERS Summary and final notes.
Bioinformatics Jan Taylor. A bit about me Biochemistry and Molecular Biology Computer Science, Computational Biology Multivariate statistics Machine learning.
FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Beyond the Human Genome Project Future goals and projects based on findings from the HGP.
National Institute of Environmental Health Sciences 04_2172 Gene-Environment Interactions in the Development of Complex Phenotypes Kenneth Olden, Ph.D.,
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Tjalling Jager Dept. Theoretical Biology Assessing ecotoxicological effects on a mechanistic basis the central role of the individual.
Center for Human Health and the Environment
Data Analysis Summary. Elephant in the room General Comments General understanding that informatics is integral in medical sequencing and other –omics.
Integrated Biomedical Information for Better Health Workprogramme Call 4 IST Conference- Networking Session.
William A. Craig Symposium ISAP Research Meeting PK/PD and Genomics David Andes University of Wisconsin.
COMPUTATIONAL ANALYSIS OF MULTILEVEL OMICS DATA FOR THE ELUCIDATION OF MOLECULAR MECHANISMS OF CANCER Presented by Azeez Ayomide Fatai Supervisor: Junaid.
Bioinformatics MEDC601 Lecture by Brad Windle Ph# Office: Massey Cancer Center, Goodwin Labs Room 319 Web site for lecture:
Bioinformatics and Computational Biology
First Annual Meeting. Pioneering the Use of Genomic Biomarkers in Assessing Risk to Environmental and Human Health An established and effective collaboration.
Lecture 11. Topics in Omic Studies (Cancer Genomics, Transcriptomics and Epignomics) The Chinese University of Hong Kong CSCI5050 Bioinformatics and Computational.
A Report on CAMDA’01 Biointelligence Lab School of Computer Science and Engineering Seoul National University Kyu-Baek Hwang and Jeong-Ho Chang.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Challenges in Bioinformatics R.W. Doerge Department of Statistics Department Agronomy.
The type of target influence the type of drug Main drugs’ categories –Small molecules –Biologicals (e.g. antibodies, hormones, etc) The drug discovery.
Module 5: Future 1 Canadian Bioinformatics Workshops
Bioinformatics Dipl. Ing. (FH) Patrick Grossmann
PLANT BIOTECHNOLOGY & GENETIC ENGINEERING (3 CREDIT HOURS) LECTURE 13 ANALYSIS OF THE TRANSCRIPTOME.
Elena Klenova CTCF and BORIS in normal development, epigenetics and tumourigenesis Areas of research: Molecular Oncology Gene regulation Translational.
Notes: Human Genome (Right side page)
Human Genomics Higher Human Biology. Learning Intentions Explain what is meant by human genomics State that bioinformatics can be used to identify DNA.
Toxicogenomics Dr. M. Zdanowicz.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Higher Human Biology Sub topic 5 (a)
Conceptual approach for incorporating “omics” technologies and resulting large databases into toxicological evaluation. Data from experiments that evaluate.
“Proteomics is a science that focuses on the study of proteins: their roles, their structures, their localization, their interactions, and other factors.”
Relationship between Genotype and Phenotype
By Michael Fraczek and Caden Boyer
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Schedule for the Afternoon
Relationship between Genotype and Phenotype
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Chapter 10 – The Gene and Protein Synthesis
Integrative omic approaches for the study of host–pathogen interactions Integrative omic approaches for the study of host–pathogen interactions (A) Proteomic.
Genome‐scale metabolic models (GEMs) provide a scaffold for integrative analysis of clinical data. Genome‐scale metabolic models (GEMs) provide a scaffold.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Presentation transcript:

TOXICOGENOMICS

TOXICOGENOMICS Is the study of the response of a genome to environmental stressors and toxicants (Waters, et al 2003). It combines genomics-transcriptomics, proteomics, metabonomics/metabolomics, and bioinformatics with conventional toxicology.

TOXICOGENOMICS Genomics: the study of genes in the aggregate- DNA, the primary transcript and mRNA. If we assume there is some change in gene expression in response to toxicity, then expression profiling is an extremely powerful tool to a asses a specific response to environmental exposures.

TOXICOGENOMICS Proteomics: the study of protein products in aggregate-it applies to the translation from the mRNA to the primary protein products, and their maduration and modification to yield active proteins.

TOXICOGENOMICS Metabonomics/Metabo lomics Furthermore, metabolites are the last step in the molecular response to a toxicants.

TOXICOGENOMICS Toxicogenomics has three principals goals (Waters, MD. et al 2004): Understand the relationship between environmental stress and human disease susceptibility. Identify useful biomarkers of disease and exposure to toxic substances. Elucidate the molecular mechanisms of toxicity.

Elucidate the molecular mechanisms of toxicity Understand the relationship between environmental stress and human disease susceptibility. Elucidate the molecular mechanisms of toxicity

Identify useful biomarkers of disease and exposure to toxic substances.

TOXICOGENOMICS NCT (National Center for Toxicogenomics) has created a public database of environmetal effects of toxic substances in biological systems, CEBS. CEBS had two majors goals (Waters, MD. et al 2003): Create a reference toxicogenomics information. Develope a compendia on toxicologically important genes, groups of genes, SNPs, and mutant and knockout phenotypes in animal models relevant to human health and environmental disease.

CEBS has incorporated high-quality data sets from each of new toxicogenomics technologies as well as from contemporary molecular and celular toxicology. http://cebs.niehs.nih.gov./

TOXICOGENOMICS Limitations: Difficulty in analysis of high density data. Difficulty in integration of data obtained by different technologies. Difficulty in linking “omics” data to specific adverse effects. Difficulty in translation statistical assessments into biological understanding. Limitations of incomplete functional annotation of genome data bases. Incomplete knowledge of functional pathways and networks, particularly trans-genome relationship.

TOXICOGENOMICS The future of toxicogenomics: Genomic technologies provides an opportunity to asses the problematic relationship between environmental exposure and disease. Identify biomarkers of incipient adverse effects, that will be more specific and sensitive than available now. Provide a rational basis for risk assesment. Facilitate the identification of specific susceptibility polymorphisms and relate them to environmental diseases. Facilitate the development on new drugs- impact on pharmaceutical industry. Keep on improve the CEBS knowledge base, specially in human data.

TOXICOGENOMICS References: Waters, MD., Fostel, JM. Toxicogenomics and systems toxicology: aims and prospects. Nature (2004);5:936-948. Waters, MD., Selrik, JK., Olden, K. The impact of new technologies on human population studies. Mutation Research (2003);544:349-360. Waters, MD., Olden, K., Tennant, RW. Toxicogenomic approach for assesing toxicant-related disease. Mutation Research (2003);544:415-424. http://cebs.niehs.nih.gov/